Patents

Exclusive Interview with ASBM Released Ahead of Upcoming Biosimilars Conference

https://pharmaphorum.com/partner-content/exclusive-interview-with-asbm-released-ahead-of-upcoming-biosimilars-conference/

UK pharma patents up 20%, new report finds

https://pharmaphorum.com/news/uk-pharma-patents-up-20-new-report-finds/

Teva and Neos settle over Cotempla patent dispute

https://pharmaphorum.com/news/teva-and-neos-settle-over-cotempla-patent-dispute/

Will plausibility reign supreme in Lyrica second medical use patent case?

https://pharmaphorum.com/views-analysis-market-access/will-plausibility-reign-supreme-in-lyrica-second-medical-use-patent-case/

Local partnerships key to pharma’s success in China

https://pharmaphorum.com/views-and-analysis/local-partnerships-key-pharmas-success-china/

Biotech association steps in to fight growth of ‘plausibility’ patent challenges

https://pharmaphorum.com/news/biotech-association-steps-fight-growth-plausibility-patent-challenges/

Increasing access to medicines: A critical look at pharmaceutical patents

https://pharmaphorum.com/views-and-analysis/increasing-access-to-medicines-a-critical-look-at-pharmaceutical-patents/

Making the case for pharmaceutical IP management

https://pharmaphorum.com/views-and-analysis/making-case-pharmaceutical-ip-management/

Recent trends in ANDA litigation

https://pharmaphorum.com/views-and-analysis/recent-trends-anda-litigation/

Close in 10 seconds

Pharmaphorum.com

Search